Dr. Maro Ohanian
Claim this profileM D Anderson Cancer Center
Area of expertise
Acute Myeloid Leukemia
Maro Ohanian has run 7 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Myelodysplastic Syndrome
Maro Ohanian has run 4 trials for Myelodysplastic Syndrome. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
University Of Texas MD Anderson Cancer Center
Clinical Trials Maro Ohanian is currently running
Dexrazoxane
for Blood Cancer Side Effects
This phase II trial studies how well dexrazoxane hydrochloride works in preventing heart-related side effects of chemotherapy in participants with blood cancers, such as acute myeloid leukemia, myelodysplastic syndrome, chronic myeloid leukemia, and myeloproliferative neoplasms. Chemoprotective drugs, such as dexrazoxane hydrochloride, may protect the heart from the side effects of drugs used in chemotherapy, such as cladribine, idarubicin, cytarabine, and gemtuzumab ozogamicin, in participants with blood cancers.
Recruiting
1 award
Phase 2
19 criteria
BP1002 + Decitabine
for Acute Myeloid Leukemia
This study evaluates the safety and tolerability of escalating doses of BP1002 (Liposomal Bcl-2 Antisense Oligodeoxynucleotide) in patients with refractory/relapsed AML. The study is designed to assess the safety profile, identify DLTs, biologically effective doses, PK, PD and potential anti-leukemic effects of BP1002 as single agent (dose escalation phase) followed by assessing BP1002 in combination with decitabine (dose expansion phase).
Recruiting
1 award
Phase 1
11 criteria
More about Maro Ohanian
Clinical Trial Related
7 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Maro Ohanian has experience with
- Decitabine
- Bortezomib
- Clofarabine
- Cyclophosphamide
- Dexamethasone
- Etoposide
Breakdown of trials Maro Ohanian has run
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Relapse
Myeloproliferative Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maro Ohanian specialize in?
Maro Ohanian focuses on Acute Myeloid Leukemia and Myelodysplastic Syndrome. In particular, much of their work with Acute Myeloid Leukemia has involved Philadelphia chromosome positive patients, or patients who are t(8;21) negative.
Is Maro Ohanian currently recruiting for clinical trials?
Yes, Maro Ohanian is currently recruiting for 6 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Maro Ohanian has studied deeply?
Yes, Maro Ohanian has studied treatments such as Decitabine, Bortezomib, Clofarabine.
What is the best way to schedule an appointment with Maro Ohanian?
Apply for one of the trials that Maro Ohanian is conducting.
What is the office address of Maro Ohanian?
The office of Maro Ohanian is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.